title: Receptor-associated protein (RAP) plays a central role in modulating Abeta deposition in APP/PS1 transgenic mice.
abstract: BACKGROUND
  Receptor associated protein (RAP) functions in the endoplasmic reticulum (ER) to assist in the maturation of several membrane receptor proteins, including low density lipoprotein receptor-related protein (LRP) and lipoprotein receptor 11 (SorLA/LR11). Previous studies in cell and mouse model systems have demonstrated that these proteins play roles in the metabolism of the amyloid precursor protein (APP), including processes involved in the generation, catabolism and deposition of beta-amyloid (Abeta) peptides.
  
  
  RESULTS
  Mice transgenic for mutant APPswe and mutant presenilin 1 (PS1dE9) were mated to mice with homozygous deletion of RAP. Unexpectedly, mice that were homozygous null for RAP and transgenic for APPswe/PS1dE9 showed high post-natal mortality, necessitating a shift in focus to examine the levels of amyloid deposition in APPswe/PS1dE9 that were hemizygous null for RAP. Immunoblot analysis confirmed 50% reductions in the levels of RAP with modest reductions in the levels of proteins dependent upon RAP for maturation [LRP trend towards a 20% reduction ; SorLA/LR11 statistically significant 15% reduction (p<0.05)]. Changes in the levels of these proteins in the brains of [APPswe/PS1dE9](+/-)/RAP(+/-) mice correlated with 30-40% increases in amyloid deposition by 9 months of age.
  
  
  CONCLUSIONS
  Partial reductions in the ER chaperone RAP enhance amyloid deposition in the APPswe/PS1dE9 model of Alzheimer amyloidosis. Partial reductions in RAP also affect the maturation of LRP and SorLA/LR11, which are each involved in several different aspects of APP processing and Abeta catabolism. Together, these findings suggest a central role for RAP in Alzheimer amyloidogenesis.
authors.affiliation: Department of Neuroscience, McKnight Brain Institute, Santa Fe Health Alzheimer's Disease Research Center, University of Florida, Gainesville, Florida, United States of America.
authors.forename: Guilian
authors.initials: G
authors.lastname: Xu
authors.forename: Celeste
authors.initials: C
authors.lastname: Karch
authors.forename: Ning
authors.initials: N
authors.lastname: Li
authors.forename: Nianwei
authors.initials: N
authors.lastname: Lin
authors.forename: David
authors.initials: D
authors.lastname: Fromholt
authors.forename: Victoria
authors.initials: V
authors.lastname: Gonzales
authors.forename: David R
authors.initials: DR
authors.lastname: Borchelt
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000737:chemistry*; D000818:Animals; D002460:Cell Line; D004721:Endoplasmic Reticulum / Q000378:metabolism; D017353:Gene Deletion; D006720:Homozygote; D026563:LDL-Receptor Related Protein-Associated Protein / Q000378:metabolism / Q000502:physiology*; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000737:chemistry; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D053764:Presenilin-1 / Q000235:genetics*; D018110:Receptors, Lipoprotein / Q000737:chemistry
chemical_list: D016229:Amyloid beta-Peptides; D026563:LDL-Receptor Related Protein-Associated Protein; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D053764:Presenilin-1; D018110:Receptors, Lipoprotein
references.citation: J Biol Chem. 2005 Apr 15;280(15):15464-70
references.pmid: 15705569
references.citation: J Neurosci. 2000 Jun 1;20(11):4050-8
references.pmid: 10818140
references.citation: J Neuropathol Exp Neurol. 2003 Oct;62(10):999-1005
references.pmid: 14575236
references.citation: Neurology. 2006 Jan 24;66(2 Suppl 1):S69-73
references.pmid: 16432149
references.citation: J Clin Invest. 2000 Nov;106(9):1159-66
references.pmid: 11067868
references.citation: Alzheimer Dis Assoc Disord. 2002 Jul-Sep;16(3):191-5
references.pmid: 12218651
references.citation: Exp Neurol. 2001 Jul;170(1):15-26
references.pmid: 11421580
references.citation: Science. 1993 Aug 13;261(5123):921-3
references.pmid: 8346443
references.citation: Cell. 1995 Jul 28;82(2):331-40
references.pmid: 7543026
references.citation: Neuropathol Appl Neurobiol. 1986 Jan-Feb;12(1):3-9
references.pmid: 2422580
references.citation: Biomol Eng. 2001 Jun;17(6):157-65
references.pmid: 11337275
references.citation: Hum Mol Genet. 2001 Oct 15;10(22):2525-37
references.pmid: 11709540
references.citation: J Biol Chem. 1996 Dec 6;271(49):31379-83
references.pmid: 8940146
references.citation: J Mol Med (Berl). 1999 Mar;77(3):306-15
references.pmid: 10090593
references.citation: J Biol Chem. 2005 May 20;280(20):20140-7
references.pmid: 15772078
references.citation: Nat Genet. 2007 Feb;39(2):168-77
references.pmid: 17220890
references.citation: PLoS Med. 2005 Dec;2(12):e355
references.pmid: 16279840
references.citation: Neuron. 1996 Jul;17(1):181-90
references.pmid: 8755489
references.citation: J Biol Chem. 2004 Jul 9;279(28):29639-46
references.pmid: 15126508
references.citation: Proc Natl Acad Sci U S A. 1995 May 9;92(10):4537-41
references.pmid: 7538675
references.citation: Neurogenetics. 1998 Mar;1(3):179-83
references.pmid: 10737120
references.citation: J Neurosci. 2004 Apr 28;24(17):4259-65
references.pmid: 15115822
references.citation: J Clin Invest. 2000 Dec;106(12):1489-99
references.pmid: 11120756
references.citation: Stroke. 2004 Nov;35(11 Suppl 1):2628-31
references.pmid: 15459432
references.citation: EMBO J. 1990 Jun;9(6):1769-76
references.pmid: 2112085
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13461-6
references.pmid: 16174740
references.citation: Brain Res Mol Brain Res. 2001 Mar 5;87(2):238-45
references.pmid: 11245926
references.citation: J Neurochem. 1999 Oct;73(4):1393-8
references.pmid: 10501182
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):1075-80
references.pmid: 14732699
references.citation: J Biol Chem. 2000 Mar 10;275(10):7410-5
references.pmid: 10702315
references.citation: J Neurochem. 1997 Nov;69(5):1904-11
references.pmid: 9349534
references.citation: EMBO J. 1995 May 15;14(10):2269-80
references.pmid: 7774585
references.citation: Arch Neurol. 1997 Oct;54(10):1289-92
references.pmid: 9341576
references.citation: J Clin Invest. 2001 Sep;108(6):779-84
references.pmid: 11560943
references.citation: Neurobiol Dis. 2003 Apr;12(3):194-211
references.pmid: 12742740
references.citation: Microsc Res Tech. 2000 Aug 15;50(4):268-72
references.pmid: 10936878
references.citation: Neurosci Lett. 1997 May 9;227(1):68-70
references.pmid: 9178861
references.citation: Biol Chem. 1998 Aug-Sep;379(8-9):1025-31
references.pmid: 9792434
references.citation: Mol Cell Neurosci. 1999 Aug;14(2):129-40
references.pmid: 10479411
references.citation: J Neurosci. 2002 Nov 1;22(21):9298-304
references.pmid: 12417655
references.citation: Cell. 1992 Oct 30;71(3):411-21
references.pmid: 1423604
references.citation: Neurology. 1997 Jul;49(1):56-61
references.pmid: 9222170
references.citation: Neurosci Lett. 1997 Sep 19;233(2-3):145-7
references.pmid: 9350853
references.citation: Nature. 1995 Feb 9;373(6514):523-7
references.pmid: 7845465
references.citation: Hum Mol Genet. 2004 Jan 15;13(2):159-70
references.pmid: 14645205